Interpace Biosciences IDXG
OTC IDXG
$6.05 -0.20 (-3.20%)
At close: Nov 13, 2026 · 4:00 PM EST

Interpace Biosciences (IDXG) Net Short-Term Debt Issued (Repaid) (2019 - 2023)

Updated

Interpace Biosciences (IDXG) posted Current Debt of -$2.5 million for FY2023, compared with $1 million in FY2022.

Analysis

Interpace Biosciences (IDXG) Net Short-Term Debt Issued (Repaid) (2019 - 2023) Analysis & Trends

Since FY2016, Interpace Biosciences has reported Current Debt for 6 years.

  • The FY2023 figure stands as the lowest annual Current Debt since FY2020.
  • Business Quant data shows IDXG's Current Debt at $1 million in FY2022 (-33.3%), $1.5 million in FY2021, -$3 million in FY2020 and $3 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn 828.00 Mn
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn -
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn -220.30 Mn
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn -
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn -
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn -
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn 200.00 Mn
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn -
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn -
10 Interpace Biosciences 167.59 Mn 158.32 Mn 5.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -1.50 Mn
Jun 30, 2023 -700,000.00
Mar 31, 2023 -300,000.00
Mar 31, 2022 1.00 Mn
Sep 30, 2020 -3.40 Mn
Jun 30, 2020 2.20 Mn
Mar 31, 2020 -1.80 Mn
Dec 31, 2019 -750,000.00
Mar 31, 2019 -1.80 Bn
API Access

Interpace Biosciences Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=IDXG&period=max&api_key=YOUR_API_KEY